EP2906950A4 - Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern - Google Patents

Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern

Info

Publication number: EP2906950A4
Authority: EP; European Patent Office
Prior art keywords: peptides; detection; methods; devices; ehrlichia antibodies
Prior art date: 2012-10-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP13844762.8A

Other languages

English (en)

French (fr)

Other versions

EP2906950A1 (de

EP2906950B1 (de

Inventor

Rajesh K Mehra

Kenneth P Aron

Dennis M Bleile

Timothy P Forsyth

Jeremy D Walker

Cristina R Cuesico

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abay SA

Abaxis Inc

Original Assignee

Abay SA

Abaxis Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-11

Filing date

2013-10-11

Publication date

2016-05-25

2013-10-11 Application filed by Abay SA, Abaxis Inc filed Critical Abay SA

2015-08-19 Publication of EP2906950A1 publication Critical patent/EP2906950A1/de

2016-05-25 Publication of EP2906950A4 publication Critical patent/EP2906950A4/de

2018-03-21 Application granted granted Critical

2018-03-21 Publication of EP2906950B1 publication Critical patent/EP2906950B1/de

Status Active legal-status Critical Current

2033-10-11 Anticipated expiration legal-status Critical

Links

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Pathology (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Inorganic Chemistry (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

EP13844762.8A 2012-10-11 2013-10-11 Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern Active EP2906950B1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261712578P	2012-10-11	2012-10-11
PCT/US2013/064536 WO2014059274A1 (en)	2012-10-11	2013-10-11	Peptides, devices, and methods for the detection of ehrlichia antibodies

Publications (3)

Publication Number	Publication Date
EP2906950A1 EP2906950A1 (de)	2015-08-19
EP2906950A4 true EP2906950A4 (de)	2016-05-25
EP2906950B1 EP2906950B1 (de)	2018-03-21

Family

ID=50477922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP13844762.8A Active EP2906950B1 (de)	2012-10-11	2013-10-11	Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern

Country Status (10)

Country	Link
US (5)	US9651546B2 (de)
EP (1)	EP2906950B1 (de)
JP (1)	JP6325553B2 (de)
KR (1)	KR102106762B1 (de)
CN (1)	CN105051541B (de)
AU (1)	AU2013329025B2 (de)
BR (1)	BR112015008036B1 (de)
CA (1)	CA2886989C (de)
ES (1)	ES2668863T3 (de)
WO (1)	WO2014059274A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101892182B1 (ko)	2009-11-20	2018-08-24	아박시스, 인크.	에를리키아 항체의 검출을 위한 펩티드, 장치 및 방법
FI3489685T3 (fi) *	2011-11-21	2023-12-21	Zoetis Services Llc	Signaalin vahvistaminen lateraalivirtaus- ja vastaavissa immunomäärityksissä
CN105051541B (zh)	2012-10-11	2017-07-04	爱贝斯股份有限公司	用于检测埃里希体属抗体的肽、装置和方法
US9194870B2 (en)	2014-01-21	2015-11-24	Abaxis, Inc.	Peptides, devices, and methods for the detection of Anaplasma antibodies
US9442112B2 (en) *	2014-04-04	2016-09-13	Abaxis, Inc.	Compositions and methods for identifying Ehrlichia species
TWI691716B (zh) *	2014-08-13	2020-04-21	美商艾巴希斯公司	電漿特異性結合搭配物檢定中之信號放大
CA2991532C (en)	2015-08-04	2024-03-05	Abaxis, Inc.	Signal amplification in solution-based plasmonic specific-binding partner assays
US20200209226A1 (en) *	2017-01-20	2020-07-02	Shenzhen New Industries Biomedical Engineering Co.	Labeled complex, preparation method thereof, kit containing the same, application of kit and detection system comprising kit
CN118275398A (zh)	2017-01-30	2024-07-02	硕腾服务有限责任公司	基于溶液的等离子体振子特异性结合配偶体测定和金属纳米结构
WO2019014469A1 (en) *	2017-07-12	2019-01-17	Kansas State University Research Foundation	IMMUNOGENIC COMPOSITIONS OF EHRLICHIA RUMINANTIUM AND METHODS OF USE
WO2019192978A1 (en)	2018-04-03	2019-10-10	Sanofi	Lateral flow immunoassay strip device
KR102766141B1 (ko) *	2018-09-27	2025-02-12	세키스이 메디칼 가부시키가이샤	면역 크로마토그래피용 시험편
US20240272168A1 (en) *	2023-02-14	2024-08-15	Advanced Biosystems, Inc.	Immunostaining using protein conjugates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000032745A2 (en) *	1998-11-30	2000-06-08	Research Development Foundation	Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
US20030103991A1 (en) *	1998-09-18	2003-06-05	Yasuko Rikihisa	Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
WO2008137881A2 (en) *	2007-05-04	2008-11-13	The Ohio State University Research Foundation	Ehrlichia ewingii proteins, nucleic acids, and methods of their use

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4366246A (en)	1977-11-08	1982-12-28	Genentech, Inc.	Method for microbial polypeptide expression
US4617262A (en) *	1983-07-22	1986-10-14	Cooperbiomedical, Inc.	Assaying for circulating immune complexes with labeled protein A
US6284238B1 (en)	1995-06-06	2001-09-04	Aquila Biopharmaceuticals, Inc.	Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US6451315B1 (en)	1996-10-01	2002-09-17	Corixa Corporation	Compounds and methods for the diagnosis and treatment of B. microti infection
US6653128B2 (en)	1996-10-17	2003-11-25	University Of Florida	Nucleic acid vaccines against rickettsial diseases and methods of use
US6593147B1 (en) *	1996-10-17	2003-07-15	University Of Florida Research Foundation, Inc.	Nucleic acid vaccines against rickettsial diseases and methods of use
US6207169B1 (en)	1997-03-21	2001-03-27	Corixa Corporation	Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6231869B1 (en)	1997-03-21	2001-05-15	Corixa Corporation	Compounds and methods for the diagnosis and treatment of ehrlichia infection
CA2258277C (en)	1997-04-25	2013-08-13	Antigenics Llc	Characterization of granulocytic ehrlichia and methods of use
CA2304256C (en)	1997-09-19	2014-12-09	Yasuko Rikihisa	Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
JP2002527042A (ja) *	1998-07-28	2002-08-27	アクウィラ・バイオファーマシューティカルズ・インコーポレイテッド	顆粒球エールリキア菌遺伝子およびその使用
US6043085A (en)	1998-08-27	2000-03-28	Research Development Foundation	Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
US6544517B1 (en)	1998-09-18	2003-04-08	The Ohio State University Research Foundation	Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US7888491B2 (en)	1998-09-18	2011-02-15	The Ohio State University Research Foundation	Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en)	1999-03-03	2002-05-21	Research Development Foundation	Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
WO2001007625A2 (en)	1999-07-21	2001-02-01	Cornell Research Foundation, Inc.	Ehrlichia canis genes and vaccines
US6355777B1 (en)	2000-04-28	2002-03-12	Research Development Foundation	P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
US7087372B2 (en)	2001-01-18	2006-08-08	Idexx Laboratories, Inc.	Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en)	2005-02-22	2007-02-27	Idexx Laboratories, Inc.	Peptides for detection of antibody to Ehrlichia ewingii
US7407770B2 (en)	2001-01-18	2008-08-05	Idexx Corporation	Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en)	2002-04-12	2003-10-16	O'connor Thomas Patrick	Peptides for detection of antibody to Ehrlichia equi
PT1384075E (pt)	2001-03-28	2010-03-23	Heska Corp	Métodos de detecção de doença renal inicial em animais
US20030129161A1 (en)	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
ES2293057T3 (es)	2002-11-04	2008-03-16	Research Development Foundation	Antigenos p153 y p156 para la inmunodiagnosis de ehrliquiosis canina y humana y uso de los mismos.
US7482128B2 (en)	2003-03-27	2009-01-27	Heska Corporation	Anti-feline albumin antibodies
US7304139B2 (en)	2003-10-28	2007-12-04	University Of Florida Research Foundation, Inc.	Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US20050202046A1 (en)	2004-03-11	2005-09-15	Wyeth	Canine vaccine for protection against ehrlichiosis
US20060046310A1 (en)	2004-08-25	2006-03-02	Zong-Li Xia	Amplification method for solid phase immunoassays
WO2006107924A2 (en)	2005-04-04	2006-10-12	Idexx Laboratories, Inc.	Ehrlichia canis diva (differentiate infected from vaccinated animals)
US7842474B2 (en)	2005-04-04	2010-11-30	Idexx Laboratories, Inc.	Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
EP1891095A2 (de)	2005-06-16	2008-02-27	Research Development Foundation	Immunreaktive orthologe proteine aus ehrlichia canis und e. chaffeensis
US20090176208A1 (en)	2006-01-04	2009-07-09	Simon Brodie	Methods for detecting, identifying and reporting the presence of animal pathological agents
US7776618B2 (en)	2007-03-01	2010-08-17	Church & Dwight Co., Inc.	Diagnostic detection device
US7507789B2 (en)	2007-04-09	2009-03-24	Idexx Laboratories, Inc.	Detection of Anaplasma platys
EP2203469A4 (de)	2007-09-21	2011-08-24	Idexx Lab Inc	Verfahren und zusammensetzungen zum nachweis von ehrlichia chaffeensis (p120)
EP2231696A4 (de)	2007-09-21	2012-02-15	Idexx Lab Inc	Verfahren und zusammensetzungen zum nachweis von ehrlichia chaffeensis (vlpt)
EP2215477B1 (de)	2007-10-31	2019-01-16	IDEXX Laboratories Inc	Ehrlichia canis-diva (unterscheidung von infizierten und geimpften tieren)
KR101892182B1 (ko) *	2009-11-20	2018-08-24	아박시스, 인크.	에를리키아 항체의 검출을 위한 펩티드, 장치 및 방법
CN105051541B (zh)	2012-10-11	2017-07-04	爱贝斯股份有限公司	用于检测埃里希体属抗体的肽、装置和方法
CN103060468B (zh)	2013-01-30	2014-02-12	扬州大学	一种埃里希氏菌的荧光定量pcr检测和分型的引物、探针及试剂盒
US9442112B2 (en)	2014-04-04	2016-09-13	Abaxis, Inc.	Compositions and methods for identifying Ehrlichia species

2013
- 2013-10-11 CN CN201380063495.6A patent/CN105051541B/zh active Active
- 2013-10-11 KR KR1020157010378A patent/KR102106762B1/ko active Active
- 2013-10-11 US US14/052,296 patent/US9651546B2/en active Active
- 2013-10-11 CA CA2886989A patent/CA2886989C/en active Active
- 2013-10-11 AU AU2013329025A patent/AU2013329025B2/en active Active
- 2013-10-11 EP EP13844762.8A patent/EP2906950B1/de active Active
- 2013-10-11 ES ES13844762.8T patent/ES2668863T3/es active Active
- 2013-10-11 WO PCT/US2013/064536 patent/WO2014059274A1/en not_active Ceased
- 2013-10-11 BR BR112015008036-7A patent/BR112015008036B1/pt active IP Right Grant
- 2013-10-11 JP JP2015536934A patent/JP6325553B2/ja active Active
2014
- 2014-04-14 US US14/252,690 patent/US9157913B2/en active Active
2015
- 2015-09-01 US US14/842,440 patent/US9696300B2/en active Active
2017
- 2017-05-30 US US15/608,560 patent/US10444231B2/en active Active
2019
- 2019-08-27 US US16/552,381 patent/US10948487B2/en active Active

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030103991A1 (en) *	1998-09-18	2003-06-05	Yasuko Rikihisa	Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
WO2000032745A2 (en) *	1998-11-30	2000-06-08	Research Development Foundation	Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
WO2008137881A2 (en) *	2007-05-04	2008-11-13	The Ohio State University Research Foundation	Ehrlichia ewingii proteins, nucleic acids, and methods of their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG CHUNBIN ET AL: "Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay", CLINICAL AND VACCINE IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 15, no. 3, 1 March 2008 (2008-03-01), pages 402 - 411, XP002498682, ISSN: 1556-6811, [retrieved on 20071219], DOI: 10.1128/CVI.00366-07 *

Also Published As

Publication number	Publication date
US20160054313A1 (en)	2016-02-25
US9696300B2 (en)	2017-07-04
CA2886989A1 (en)	2014-04-17
CA2886989C (en)	2022-05-17
US9157913B2 (en)	2015-10-13
BR112015008036B1 (pt)	2022-09-13
US10948487B2 (en)	2021-03-16
US20140212898A1 (en)	2014-07-31
AU2013329025A1 (en)	2015-04-23
WO2014059274A1 (en)	2014-04-17
US20190391139A1 (en)	2019-12-26
CN105051541B (zh)	2017-07-04
KR102106762B1 (ko)	2020-05-06
JP6325553B2 (ja)	2018-05-16
EP2906950A1 (de)	2015-08-19
CN105051541A (zh)	2015-11-11
EP2906950B1 (de)	2018-03-21
AU2013329025B2 (en)	2019-07-04
JP2016500815A (ja)	2016-01-14
BR112015008036A2 (pt)	2017-11-28
US20140121125A1 (en)	2014-05-01
KR20150065744A (ko)	2015-06-15
US10444231B2 (en)	2019-10-15
ES2668863T3 (es)	2018-05-22
US9651546B2 (en)	2017-05-16
US20180106792A1 (en)	2018-04-19

Legal Events

Date	Code	Title	Description
2015-07-17	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2015-08-19	17P	Request for examination filed	Effective date: 20150423
2015-08-19	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2015-08-19	AX	Request for extension of the european patent	Extension state: BA ME
2016-01-20	DAX	Request for extension of the european patent (deleted)
2016-04-19	REG	Reference to a national code	Ref country code: DE Ref legal event code: R079 Ref document number: 602013034852 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: G01N0033554000 Ipc: G01N0033680000
2016-05-25	RA4	Supplementary search report drawn up and despatched (corrected)	Effective date: 20160425
2016-05-25	RIC1	Information provided on ipc code assigned before grant	Ipc: G01N 33/569 20060101ALI20160419BHEP Ipc: G01N 33/68 20060101AFI20160419BHEP Ipc: C07K 17/14 20060101ALI20160419BHEP Ipc: G01N 33/543 20060101ALI20160419BHEP Ipc: C07K 14/29 20060101ALI20160419BHEP
2017-01-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2017-02-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2017-02-08	R17P	Request for examination filed (corrected)	Effective date: 20150423
2017-03-08	17Q	First examination report despatched	Effective date: 20170203
2017-11-09	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2017-11-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2017-12-06	INTG	Intention to grant announced	Effective date: 20171110
2018-02-10	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2018-02-16	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2018-02-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2018-03-21	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2018-03-21	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2018-03-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2018-04-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: REF Ref document number: 981684 Country of ref document: AT Kind code of ref document: T Effective date: 20180415
2018-04-18	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2018-04-19	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602013034852 Country of ref document: DE
2018-05-16	REG	Reference to a national code	Ref country code: DE Ref legal event code: R081 Ref document number: 602013034852 Country of ref document: DE Owner name: ZOETIS SERVICES LLC (N.D.GES.D.STAATES DELAWAR, US Free format text: FORMER OWNER: ABAXIS INC., UNION CITY, CALIF., US
2018-05-22	REG	Reference to a national code	Ref country code: ES Ref legal event code: FG2A Ref document number: 2668863 Country of ref document: ES Kind code of ref document: T3 Effective date: 20180522
2018-07-25	REG	Reference to a national code	Ref country code: NL Ref legal event code: MP Effective date: 20180321
2018-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180621 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321
2018-08-10	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG4D
2018-08-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 981684 Country of ref document: AT Kind code of ref document: T Effective date: 20180321
2018-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180622 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180621
2018-09-26	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6
2018-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321
2018-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321
2018-12-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180723
2019-01-02	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602013034852 Country of ref document: DE
2019-01-25	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2019-01-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2019-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321
2019-02-27	26N	No opposition filed	Effective date: 20190102
2019-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321
2019-05-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2019-06-26	REG	Reference to a national code	Ref country code: BE Ref legal event code: MM Effective date: 20181031
2019-06-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181011
2019-07-24	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2019-08-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181031 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181031
2019-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181011
2020-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181011
2020-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180321
2020-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180321 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20131011
2020-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180721
2021-04-19	REG	Reference to a national code	Ref country code: DE Ref legal event code: R082 Ref document number: 602013034852 Country of ref document: DE Representative=s name: HERNANDEZ, YORCK, DIPL.-ING., DE Ref country code: DE Ref legal event code: R081 Ref document number: 602013034852 Country of ref document: DE Owner name: ZOETIS SERVICES LLC (N.D.GES.D.STAATES DELAWAR, US Free format text: FORMER OWNER: ABAXIS, INC., UNION CITY, CA, US
2021-08-12	REG	Reference to a national code	Ref country code: ES Ref legal event code: PC2A Owner name: ZOETIS SERVICES LLC Effective date: 20210806
2023-06-28	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230523
2023-11-01	REG	Reference to a national code	Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20231005 AND 20231011
2025-10-16	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20250911 Year of fee payment: 13
2025-10-20	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20250912 Year of fee payment: 13
2026-01-08	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20250912 Year of fee payment: 13
2026-01-14	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IT Payment date: 20251013 Year of fee payment: 13
2026-01-30	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: ES Payment date: 20251105 Year of fee payment: 13

Publication	Publication Date	Title
EP2906950A4 (de)	2016-05-25	Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern
FR21C1061I2 (fr)	2022-11-18	Anticorps anti-angptl3 et utilisations de ceux-ci
EP2931356A4 (de)	2016-08-24	Verfahren und vorrichtungen zur erkennung und erfassung von biomarkern
EP2673636A4 (de)	2015-07-22	Verfahren zum nachweis therapeutischer exosome
EP2852404A4 (de)	2015-12-02	Anti-ly6e-antikörper und -immunkonjugate und verfahren zur verwendung
EP2938271A4 (de)	2016-08-24	Vorrichtungen, systeme und verfahren zur beurteilung von gefässen
EP2831279A4 (de)	2015-12-30	Schneller nachweis von aneuploidie
EP2822592A4 (de)	2016-01-06	Spezifische tgf-1-antikörper und verfahren sowie verwendungen davon
EP2847223A4 (de)	2016-01-20	Anti-b7-h6-antikörper, fusionsproteine und verfahren zur verwendung davon
EP2923428A4 (de)	2016-09-14	Erkennung von fahrzeugen oder anderen bewegten objekten
EP2906127A4 (de)	2016-06-15	Systeme und verfahren zur verankerung medizinischer vorrichtungen
EP2739951A4 (de)	2015-07-29	Kondensatorsensor, vorrichtungen mit dem kondensatorsensor und verfahren zu ihrer verwendung
EP2721140A4 (de)	2015-04-15	Vorrichtungen, lösungen und verfahren zur probenentnahme
EP2915180A4 (de)	2016-04-27	Ptychografische fourier-abbildungssysteme, -vorrichtungen und -verfahren
EP2501718A4 (de)	2014-02-19	Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern
EP2934302A4 (de)	2016-08-31	Positionierungs- und gewebeerfassungsvorrichtungen und verfahren
EP2817617A4 (de)	2016-02-17	Vorrichtungen, verfahren und testkits zum elektronischen testen von analyten
EP2864804A4 (de)	2016-07-06	Verfahren und vorrichtungen zur verbesserten positionsbestimmung
EP2768425A4 (de)	2015-05-20	Verfahren und vorrichtungen zum verbinden von nerven
EP2912178A4 (de)	2016-05-25	Superverstärker und verfahren zur verwendung davon
EP2717989A4 (de)	2015-07-01	Vesikelaufnahmevorrichtungen und verwendungsverfahren dafür
EP2773654A4 (de)	2015-04-29	Peptide und verfahren zum nachweis von lyme-erkrankungs-antikörpern
EP2831285A4 (de)	2015-10-28	Verfahren zum nachweis von anti-cytomegalovirus-neutralisierenden antikörpern
EP2854655A4 (de)	2016-03-23	Vorrichtungen und verfahren für einen magen-darm-bypass
EP2841951A4 (de)	2015-06-03	Verfahren zum nachweis von allosterischen proteinmodulatoren